£359.3 M

Dechra Pharmaceuticals Revenue FY, 2017
Dechra Pharmaceuticals Gross profit (FY, 2017)191.7 M
Dechra Pharmaceuticals Gross profit margin (FY, 2017), %53.4%
Dechra Pharmaceuticals Net income (FY, 2017)26.1 M
Dechra Pharmaceuticals EBITDA (FY, 2017)80.5 M
Dechra Pharmaceuticals EBIT (FY, 2017)33.2 M
Dechra Pharmaceuticals Cash, 30-Jun-201761.2 M
Dechra Pharmaceuticals EV1.8 B

Dechra Pharmaceuticals Revenue

Dechra Pharmaceuticals revenue was £359.28 m in FY, 2017

Embed Graph

Dechra Pharmaceuticals Income Statement

Annual

GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

137.2 m145.9 m145.5 m156.4 m170.2 m179.3 m186.8 m208.2 m232.5 m253.8 m189.2 m193.6 m203.5 m247.6 m359.3 m

Revenue growth, %

2%5%22%

Cost of goods sold

123.8 m131.4 m128.6 m137.2 m149.7 m156.3 m161.4 m178.5 m199.2 m217 m88.5 m85.9 m87.3 m115.1 m167.6 m

Gross profit

13.4 m14.5 m16.9 m19.2 m20.5 m23 m25.4 m29.7 m33.3 m36.9 m100.7 m107.7 m116.1 m132.4 m191.7 m

Gross profit Margin, %

10%10%12%12%12%13%14%14%14%15%53%56%57%53%53%

Operating expense total

7.9 m8.5 m9.4 m12 m12.1 m15.9 m16.9 m19.3 m21 m23 m82.4 m82.7 m90.2 m112.9 m158.5 m

EBITDA

15 m41 m45.5 m47.5 m44.8 m80.5 m

EBITDA margin, %

6%22%24%23%18%22%

EBIT

5.5 m6 m7.5 m7.2 m8.5 m7.1 m8.5 m10.4 m12.3 m13.8 m18.3 m25 m26 m19.5 m33.2 m

EBIT margin, %

4%4%5%5%5%4%5%5%5%5%10%13%13%8%9%

Pre tax profit

77 k417 k2.1 m4.8 m7.3 m5.7 m7.4 m8.9 m11 m12.6 m12.5 m21.4 m25.8 m14.5 m28.6 m

Income tax expense

(68 k)(246 k)(652 k)(1.7 m)(2.3 m)(1.9 m)(2.3 m)(2.6 m)(3.5 m)(3.8 m)(1.6 m)(2 m)(6.3 m)(2 m)(2.5 m)

Net Income

9 k171 k1.4 m3 m5.1 m3.8 m5.1 m6.3 m7.6 m8.8 m10.9 m19.4 m19.5 m12.5 m26.1 m

Dechra Pharmaceuticals Balance Sheet

Annual

GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

4.2 m4.7 m9.2 m4 m13.9 m19.7 m17.2 m32.8 m26.8 m45.9 m39.1 m61.2 m

Accounts Receivable

16.6 m18.7 m20.7 m23.2 m24.6 m26.8 m31.3 m31.8 m33.5 m34 m25.3 m28.3 m27.7 m59.2 m59.7 m

Inventories

9.3 m11.7 m16.2 m16.5 m19.3 m17.3 m17 m20.4 m22 m25.7 m29.2 m29.7 m31.7 m54.4 m56.5 m

Current Assets

31.3 m36 m47.9 m44.6 m45.1 m45.3 m49.9 m68 m77 m79.1 m179.5 m86.3 m108.6 m162.4 m185 m

PP&E

2.5 m2.5 m2.6 m4.3 m6.3 m5.6 m5.2 m5.2 m6 m5.7 m16.1 m18.3 m16.8 m37.7 m45.2 m

Goodwill

196.2 m166.7 m360.4 m

Total Assets

33.8 m38.5 m50.5 m48.9 m56.7 m56.6 m60.3 m78.9 m90.6 m98 m415.1 m300.8 m293.5 m556.2 m638.4 m

Accounts Payable

19.6 m23 m34.5 m31.1 m31.7 m29.2 m33.2 m38.2 m42 m44 m11.9 m12.9 m10.4 m24.3 m21.4 m

Current Liabilities

23.3 m27.9 m40.4 m39 m42.4 m42.4 m45.2 m47.2 m51.5 m55.6 m103.5 m35.7 m44.1 m66 m66.4 m

Non-Current Liabilities

40 m39.9 m37.9 m9 m8.5 m6.7 m4.9 m17.3 m15.2 m11.9 m137 m60.3 m54.9 m215.6 m270.9 m

Total Debt

5.7 m3.3 m1.4 m3 m4 m9.4 m1.6 m965 k

Total Liabilities

63.4 m67.9 m78.4 m48 m51 m49.1 m50.1 m64.5 m66.7 m67.5 m240.5 m96 m99 m281.5 m337.3 m

Additional Paid-in Capital

6 k6 k6 k498 k504 k510 k510 k511 k519 k528 k872 k877 k880 k927 k932 k

Retained Earnings

9 k171 k1.4 m1.2 m3 m1.7 m2.7 m3.6 m4.8 m5.3 m6.7 m6.8 m5.6 m(2.6 m)8.4 m

Total Equity

(29.5 m)(29.4 m)(27.9 m)901 k5.7 m7.5 m10.2 m14.5 m23.9 m30.5 m174.6 m204.8 m194.5 m274.6 m301.1 m

Debt to Equity Ratio

0.8 x0.3 x0.1 x0.1 x0.1 x0.1 x0 x0 x

Debt to Assets Ratio

0.1 x0.1 x0 x0 x0 x0 x0 x0 x

Financial Leverage

-1.1 x-1.3 x-1.8 x54.3 x9.9 x7.6 x5.9 x5.5 x3.8 x3.2 x2.4 x1.5 x1.5 x2 x2.1 x

Dechra Pharmaceuticals Cash Flow

Annual

GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

9 k171 k1.4 m3 m5.1 m3.8 m5.1 m6.3 m7.6 m8.8 m10.9 m19.4 m19.5 m12.5 m26.1 m

Cash From Operating Activities

6.4 m5.4 m12 m3.5 m6.4 m6.5 m10.6 m13.2 m9.5 m9.2 m36.9 m11.5 m41 m43.6 m77.4 m

Dividends Paid

1.9 m2.1 m2.1 m2.4 m2.7 m2.8 m3.6 m11.2 m12.6 m13.9 m15.3 m17.7 m

Cash From Financing Activities

39.9 m(1.4 m)(2.5 m)2.7 m(765 k)(3.4 m)(2.6 m)11.8 m(2.9 m)(6.7 m)(18.3 m)(92.1 m)(14.8 m)125.3 m1.6 m

Net Change in Cash

4.2 m541 k4.5 m5.2 m6.1 m3.6 m2.4 m17.2 m5.8 m(2.5 m)(769 k)(4.1 m)21.5 m(5.1 m)21.7 m

Income Taxes Paid

(2 m)(6.3 m)(2 m)

Dechra Pharmaceuticals Ratios

GBPY, 2017

EV/EBITDA

23 x

EV/EBIT

55.7 x

EV/CFO

23.9 x

Revenue/Employee

271.6 k

Financial Leverage

2.1 x
Report incorrect company information